Condensed Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities:
Net (loss) income	$ (27,082)	$ 241
Adjustments to reconcile net (loss) income to net cash used for operating activities:
Depreciation, amortization, and impairment	571	878
Gain on contract termination	(300)	0
Share-based compensation	4,696	1,749
Amortization of debt issuance costs and discounts	8,015	174
Other, net	71	(239)
Changes in operating assets and liabilities:
Trade and other receivables, net	(1,228)	(3,177)
Inventories	(252)	(1,299)
Prepaid expenses and other assets	1,083	1,217
Accounts payable	146	48
Accrued expenses and other liabilities	(2,408)	(3,469)
Deferred revenue	(12,582)	2,439
Net cash used for operating activities	(29,270)	(1,438)
Investing activities:
Capital expenditures	(144)	(979)
Net cash used for investing activities	(144)	(979)
Financing activities:
Proceeds from issuance and exercise of warrants	0	8,342
Proceeds from shares issued under employee stock purchase plan	30	31
Proceeds from exercise of stock options, net	732	0
Repayment of debt principal including lease liabilities	(18)	(12,548)
Premium paid to retire debt	0	(1,027)
Payments for taxes on share-based compensation	(1,100)	(11)
Net cash provided by financing activities	83,435	61
Net increase (decrease) in cash and cash equivalents	54,021	(2,356)
Cash and cash equivalents:
Cash and cash equivalents at beginning of period	23,872	27,273
Cash and cash equivalents at end of period	77,893	24,917
Supplemental disclosures of cash flow information:
Cash payments for income taxes	305	0
Cash payments for interest	5,566	2,827
At-the-market offering
Financing activities:
Proceeds from common stock issued under public equity offering	11,817	5,274
Public Equity Offering
Financing activities:
Proceeds from common stock issued under public equity offering	$ 71,974	$ 0